• Next Generation of mRNA Technologies

Tel: +1 (877) 974-2762
mRNA Products | Next Generation RNA Technologies
  • HOME
  • SYNTHETIC MRNA PRODUCTS
  • ORDERS
    • My Account
  • SERVICES
  • ABOUT
    • Blog
    • Testimonials
  • CONTACT
  • Menu
  • 0Shopping Cart
Awaiting product image
×
***The minimum order quantity for international customers (outside of the United States) is 1,000 μg***

Categories


REPORTER PROTEINS CELL LINEAGE SPECIFIC FACTORS GROWTH FACTORS GROWTH FACTOR RECEPTORS CYTOKINES CYTOKINE RECEPTORS GENOME INTEGRITY APOPTOSIS INNATE IMMUNITY DEVELOPMENTAL BIOLOGY MISCELLANEOUS

Customer Registration

  • Register
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

BioCapTM NFKB1 mRNA

Catalog Number: 1800201
SKUPriceBuy
1800201-500ug$2,805.00
Ships in ~10 business days

Description

GENE NAME (BOLD) / SYNONYMS:

NFKB1

SPECIES:

Human

ENCODED PROTEIN NAME:

Nuclear factor NF-kappa-B p105 subunit

Function:

NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NF-kappa-B p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p105 and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. In a complex with MAP3K8, NFKB1/p105 represses MAP3K8-induced MAPK signaling; active MAP3K8 is released by proteasome-dependent degradation of NFKB1/p105. (Source: UniProt http://www.uniprot.org/uniprot/p19838)

Sequence (968 aa):

MAEDDPYLGR PEQMFHLDPS LTHTIFNPEV FQPQMALPTD GPYLQILEQP KQRGFRFRYV CEGPSHGGLP GASSEKNKKS YPQVKICNYV GPAKVIVQLV TNGKNIHLHA HSLVGKHCED GICTVTAGPK DMVVGFANLG ILHVTKKKVF ETLEARMTEA CIRGYNPGLL VHPDLAYLQA EGGGDRQLGD REKELIRQAA LQQTKEMDLS VVRLMFTAFL PDSTGSFTRR LEPVVSDAIY DSKAPNASNL KIVRMDRTAG CVTGGEEIYL LCDKVQKDDI QIRFYEEEEN GGVWEGFGDF SPTDVHRQFA IVFKTPKYKD INITKPASVF VQLRRKSDLE TSEPKPFLYY PEIKDKEEVQ RKRQKLMPNF SDSFGGGSGA GAGGGGMFGS GGGGGGTGST GPGYSFPHYG FPTYGGITFH PGTTKSNAGM KHGTMDTESK KDPEGCDKSD DKNTVNLFGK VIETTEQDQE PSEATVGNGE VTLTYATGTK EESAGVQDNL FLEKAMQLAK RHANALFDYA VTGDVKMLLA VQRHLTAVQD ENGDSVLHLA IIHLHSQLVR DLLEVTSGLI SDDIINMRND LYQTPLHLAV ITKQEDVVED LLRAGADLSL LDRLGNSVLH LAAKEGHDKV LSILLKHKKA ALLLDHPNGD GLNAIHLAMM SNSLPCLLLL VAAGADVNAQ EQKSGRTALH LAVEHDNISL AGCLLLEGDA HVDSTTYDGT TPLHIAAGRG STRLAALLKA AGADPLVENF EPLYDLDDSW ENAGEDEGVV PGTTPLDMAT SWQVFDILNG KPYEPEFTSD DLLAQGDMKQ LAEDVKLQLY KLLEIPDPDK NWATLAQKLG LGILNNAFRL SPAPSKTLMD NYEVSGGTVR ELVEALRQMG YTEAIEVIQA ASSPVKTTSQ AHSLPLSPAS TRQQIDELRD SDSVCDSGVE TSFRKLSFTE SLTSGASLLT LNKMPHDYGQ EGPLEGKI

Gene Coding Sequence:

For the DNA coding sequence that is used as the template to synthesize the NFKB1 mRNA mimetic, please contact us at customerservice@pharna.com.

For potential mRNA mimetics encoding splice variants or isoforms of your interest, please contact us at customerservice@pharna.com and it is our promise to fulfill your needs.


Related products

  • BioCapTM EIF2AK2 (PKR) mRNA

    $1,705.00 – $2,227.50
    Select options

    BioCapTM EIF2AK2 (PKR) mRNA

    Interferon-induced, double-stranded RNA-activated protein kinase

    SKU: 1800601 Category: Innate Immunity
    $1,705.00 – $2,227.50
  • BioCapTM TLR3 mRNA

    $2,227.50
    Select options

    BioCapTM TLR3 mRNA

    Toll-like receptor 3

    SKU: 1800901 Category: Innate Immunity
    $2,227.50
  • BioCapTM MYD88 mRNA

    $1,705.00 – $2,227.50
    Select options

    BioCapTM MYD88 mRNA

    Myeloid differentiation primary response protein MyD88

    SKU: 1800101 Category: Innate Immunity
    $1,705.00 – $2,227.50
  • BioCapTM NFKB2 mRNA

    $2,227.50
    Select options

    BioCapTM NFKB2 mRNA

    Nuclear factor NF-kappa-B p100 subunit

    SKU: 1800301 Category: Innate Immunity
    $2,227.50
© Copyright 2023 - PhaRNA
  • Linkedin
  • Gplus
  • HOME
  • SYNTHETIC MRNA PRODUCTS
  • ORDERS
  • SERVICES
  • ABOUT
  • CONTACT
BioCapTM... BioCapTM...
MENU
  • HOME
  • SYNTHETIC MRNA PRODUCTS
  • ORDERS
    • My Account
  • SERVICES
  • ABOUT
    • Blog
    • Testimonials
  • CONTACT
Scroll to top